Lung cancer is a complex disease with various risk factors, and early detection is crucial for improving outcomes.
Get the full solved assignment PDF of MME-106/As-2 of 2024 session now.
Here are the risk factors associated with lung cancer and the investigations required for its diagnosis:
**Risk Factors:**
- **Tobacco Smoking:** Cigarette smoking is the leading cause of lung cancer. The risk increases with the duration and intensity of smoking, as well as exposure to secondhand smoke.
- **Exposure to Secondhand Smoke:** Non-smokers exposed to secondhand smoke are at increased risk of developing lung cancer.
- **Occupational Exposure:** Occupational exposure to carcinogens such as asbestos, radon, arsenic, chromium, nickel, and diesel fumes can increase the risk of lung cancer.
- **Environmental Factors:** Exposure to environmental pollutants, including air pollution and indoor pollutants such as cooking fumes and wood smoke, may contribute to the development of lung cancer.
- **Genetic Factors:** Family history of lung cancer and genetic predisposition, including certain genetic mutations such as mutations in the EGFR and ALK genes, may increase the risk of lung cancer.
- **Radiation Exposure:** Previous radiation therapy to the chest for other medical conditions, such as breast cancer or lymphoma, can increase the risk of developing lung cancer.
- **Lung Diseases:** Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and tuberculosis, are associated with an increased risk of lung cancer.
- **Personal History of Cancer:** Individuals with a history of lung cancer or other types of cancer are at higher risk of developing lung cancer.
**Investigations Required:**
1. **Imaging Studies:**
– Chest X-ray: Often the initial imaging study performed to evaluate lung abnormalities, though it may not detect small or early-stage tumors.
– Computed Tomography (CT) Scan: Provides detailed images of the lungs and is more sensitive than chest X-ray for detecting lung nodules and assessing tumor size, location, and spread.
2. **Sputum Cytology:** Examination of sputum under a microscope to identify cancer cells, particularly useful for diagnosing central (proximal) lung tumors.
3. **Biopsy:**
– Bronchoscopy: A procedure in which a thin, flexible tube with a camera (bronchoscope) is inserted into the airways to visualize the lungs and obtain tissue samples (biopsies) for analysis.
– Needle Biopsy: Involves inserting a thin needle through the skin or chest wall to obtain tissue samples from lung nodules or masses for pathological examination.
4. **Bronchoalveolar Lavage (BAL):** Procedure in which fluid is injected into a lung segment and then collected for analysis to detect cancer cells or other abnormalities.
5. **Positron Emission Tomography (PET) Scan:** A nuclear medicine imaging test that helps determine the extent of cancer spread (staging) by detecting areas of increased metabolic activity in the body.
6. **Molecular Testing:** Testing for specific genetic mutations or biomarkers, such as EGFR mutations or ALK rearrangements, to guide targeted therapy decisions in patients with advanced non-small cell lung cancer (NSCLC).
7. **Pulmonary Function Tests (PFTs):** Assess lung function and capacity, particularly important for evaluating patients with respiratory symptoms or underlying lung disease.
- **Blood Tests:** Measurement of tumor markers such as carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA 21-1) may be helpful in monitoring treatment response and detecting disease recurrence.
Early detection and diagnosis of lung cancer are critical for timely intervention and improved outcomes. Screening programs, such as low-dose CT screening for high-risk individuals, can help detect lung cancer at earlier stages when treatment is more effective. Additionally, smoking cessation interventions and efforts to reduce exposure to environmental carcinogens are essential for lung cancer prevention.